The CEO who loves AI autodidacts — and desperately needs his experts
Bob Bradway bet on AI before almost anyone else in biotech.
AI Summary Powered by Happening Now AI
Bob Bradway bet on AI before almost anyone else in biotech. Now Amgen is reaping the rewards — and wrestling with what it means for its scientists.
Read full article on FortuneAI summaries can be wrong sometimes—always verify important details using the source article.
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNow